Remaley, Alan Thomas
- National Heart, Lung, and Blood Institute (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #922
- Sustained Excellence
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$4.4M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#922
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Remaley, Alan Thomas as a PI. Multi-PI records show the full award amount for context.
- 1ZIAHL006243-05ZIAContact PIRole of fatty acids in health and disease.$1.5Maward amount
- 1ZIAHL006095-14ZIAContact PIDevelopment of Apo Mimetic Peptides for the Treatment Cardiovascular Disease$1.5Maward amount
- 1ZIAHL006275-02ZIAContact PIDevelopment and assessment of cardiovascular risk biomarkers$1.5Maward amount
Award organization
Organizations that administered FY2023 awards listing Remaley, Alan Thomas as a PI.
FY2023 award administered by National Heart, Lung, and Blood Institute ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardNational Heart, Lung, and Blood Institute
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007$2M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #1125
- 2007Entered Top 25% NationallyRanked #1125
- 2007Entered Top 10% NationallyRanked #1125
- 2008$5M Cumulative Funding
- 2010$10M Cumulative Funding
- 2014$25M Cumulative Funding
- 2016Entered Top 5% NationallyRanked #991
- 2021$50M Cumulative Funding